Stay updated on Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s revision indicator was updated to v3.6.3, indicating a minor site update. This does not modify the study details or related data.
    Difference
    0.1%
    Check dated 2026-07-04T04:25:38.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A classic NEJM trial reference on preoperative chemotherapy plus surgery for NSCLC was added, and the site revision tag was updated from v3.6.0 to v3.6.2.
    Difference
    0.1%
    Check dated 2026-06-27T03:05:41.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Adds a literature citation for pembrolizumab in non-small-cell lung cancer (N Engl J Med. 2015;372:2018-2028) to provide background context for the drug's use in NSCLC.
    Difference
    0.1%
    Check dated 2026-06-19T22:09:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study record adds a named contact entry (Myung-Ju Ahn) and new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study), and adjusts the Intervention/Treatment label and related status wording.
    Difference
    1%
    Check dated 2026-06-12T16:30:21.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a recent editorial/system update to the page rather than a modification to study content.
    Difference
    0.1%
    Check dated 2026-06-05T12:18:37.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.5.3 to v3.5.4, indicating a minor platform update. There is no evidence of changes to the study details or other content on the page.
    Difference
    0.1%
    Check dated 2026-05-15T03:14:37.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.